Alyssa Mages, BS, CVT, FVTE, shares guidance on assessing emergency patients, communicating with distressed clients, and establishing a team-based triage process.
|Videos|November 17, 2021
Exploring alternative cancer treatments
Author(s)Caitlin McCafferty, Content Producer
In this video interview with dvm360®, Jenny Fisher, RVT, VTS, reviewed several ways veterinary professionals are treating their patients with cancer.
Advertisement
At the New York Vet Show in New York, New York, Jenny Fisher, RVT, VTS, highlighted various alternative treatment options for oncology patients, ranging from new medications that are coming out to targeted vaccinations.
View the video below for the entire discussion. The following is a partial transcript:
Jenny Fisher, RVT, VTS: Cancer is one of those ever-evolving disease processes that luckily, we are starting to see more and more types of immunotherapy coming forth that we are seeing in human medicine as well—which is not only adding tools to our toolbox for what we can treat with or what we have to treat with, but it also gives us something else if our conventional therapies are not working.
Advertisement
Advertisement
Related to this article
In an interview with dvm360 at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker explained how the role supports owners and staff through a difficult patient diagnosis, treatment, and end-of-life care.
The Positive Preventive Veterinary Experience Protocol approach combines environmental changes, pain-reduction techniques, sensory distraction, and positive reinforcement to make preventive visits less stressful for pets and their owners.
A technician’s approach to veterinary trauma
dvm360's Australian correspondent Phil Tucak, BSc, BVMS, reports on the success of the new membership model at the Australian Veterinary Association, and reforms to the veterinary regulatory framework in New South Wales.
A new cost analysis finds that matching relapsed lymphoma treatment to a personalized drug-response test was associated with longer disease control and a lower estimated daily treatment cost in dogs.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited the growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in vivo study in dogs with naturally occurring tumors.
Advertisement
Advertisement